Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics
Source abstract
Abstract
With the development of nanotechnology, various types of polymer-based drug delivery systems have been designed for biomedical applications. Polymer-based drug delivery systems with desirable biocompatibility can be efficiently delivered to tumor sites with passive or targeted effects and combined with other therapeutic and imaging agents for cancer theranostics. As an effective vehicle for drug and gene delivery, polyethyleneimine (PEI) has been extensively studied due to its rich surface amines and excellent water solubility. In this work, we summarize the surface modifications of PEI to enhance biocompatibility and functionalization. Additionally, the synthesis of PEI-based nanoparticles is discussed. We further review the applications of PEI-based drug delivery systems in cancer treatment, cancer imaging, and cancer theranostics. Finally, we thoroughly consider the outlook and challenges relating to PEI-based drug delivery systems.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou 515063, China
Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou 515041, China
Funding
Natural Science Foundation of Guangdong Province · STU Scientific Research Foundation for Talents · 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant
References (100+)
Show source-provided references
1. Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment10.1186/s11671-021-03489-z ↗
2. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers10.1002/jcp.29126 ↗
3. Nanoparticles in cancer therapy and diagnosis10.1016/S0169-409X(02)00044-3 ↗
4. Nanoparticle therapeutics: An emerging treatment modality for cancer10.1038/nrd2614 ↗
5. Lanthanide(III) complexes of tris(amide) PCTA derivatives as potential bimodal magnetic resonance and optical imaging agents10.1002/chem.200901095 ↗
6. Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases10.1016/j.biomaterials.2014.02.030 ↗
7. Dendrimers in Cancer Therapeutics and Diagnosis10.2174/138920012802850010 ↗
8. Docetaxel-Loaded Hyaluronic Acid-Cathepsin B-Cleavable-Peptide-Gold Nanoparticles for the Treatment of Cancer10.1021/acs.molpharmaceut.8b00640 ↗
9. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation10.7150/thno.42234 ↗
10. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma10.1016/j.biomaterials.2011.10.085 ↗
11. Polymeric micelles in cancer therapy: State of the art10.1016/j.jconrel.2021.02.016 ↗
12. Doxorubicin-loaded composite nanogels for cancer treatment10.1016/j.jconrel.2020.08.033 ↗
13. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy10.1016/j.apsb.2021.05.016 ↗
14. Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy10.1039/C9MH01725A ↗
15. Radionuclide-labeled nanostructures for in vivo imaging of cancer10.1186/s40580-014-0041-3 ↗
16. Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy10.1002/smll.202001251 ↗
17. Iron oxide nanoparticles as a drug carrier reduce host immunosuppression for enhanced chemotherapy10.1039/D1NR07750C ↗
18. Immunologically modified MnFe2O4 nanoparticles to synergize photothermal therapy and immunotherapy for cancer treatment10.1016/j.cej.2020.125239 ↗
19. BSA-bioinspired gold nanorods loaded with immunoadjuvant for the treatment of melanoma by combined photothermal therapy and immunotherapy10.1039/C8NR05323E ↗
20. Lungu, C.N., Diudea, M.V., Putz, M.V., and Grudzinski, I.P. (2016). Linear and Branched PEIs (Polyethylenimines) and Their Property Space. Int. J. Mol. Sci., 17.10.3390/ijms17040555 ↗
21. Surface modification and PEGylation of branched polyethyleneimine for improved biocompatibility10.1002/app.38444 ↗
22. Antibacterial and non-cytotoxic ultra-thin polyethylenimine film10.1016/j.msec.2016.10.064 ↗
23. Polyethylenimine In Medicinal Chemistry10.2174/092986708786242778 ↗
24. Synthesis and Characterization of PEGylated Polyethylenimine-Entrapped Gold Nanoparticles for Blood Pool and Tumor CT Imaging10.1021/am505006z ↗
25. PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging10.1016/j.colsurfb.2016.01.019 ↗
26. Evaluation of the efficiency of polyethylenimine as flocculants in the removal of oil present in produced water10.1016/j.colsurfa.2018.08.085 ↗
27. Hyperbranched polyethylenimine functionalized silica/polysulfone nanocomposite membranes for water purification10.1016/j.chemosphere.2021.133363 ↗
28. Polyethylenimine: A very useful ionic polymer in the design of immobilized enzyme biocatalysts10.1039/C7TB01639E ↗
29. Polyethylenimine surface layer for enhanced virus immobilization on cellulose10.1016/j.apsusc.2016.02.165 ↗
30. Polyethylenimine/silk fibroin multilayers deposited nanofibrics for cell culture10.1016/j.ijbiomac.2016.10.047 ↗
31. Enhanced gene transfection efficiency by low-dose 25 kDa polyethylenimine by the assistance of 1.8 kDa polyethylenimine10.1080/10717544.2018.1510065 ↗
32. Polyethylenimine incorporation into hydrogel nanomatrices for enhancing nanoparticle-assisted chemotherapy10.1039/C6RA02414A ↗
33. Advances in the chemistry of polyethyleneimine (polyaziridine)10.1070/RC1965v034n07ABEH001499 ↗
34. Facile Gene Delivery Derived from Branched Low Molecular Weight Polyethylenimine by High Efficient Chemistry10.1166/jbn.2018.2620 ↗
35. Interlock Protective System from Hyperbranched Polyethyleneimine and Choline Phosphate Liposome for Targeted In Vivo Gene Delivery10.1002/admi.202201390 ↗
36. Surface chemistry of spiky silica nanoparticles tailors polyethyleneimine binding and intracellular DNA delivery10.1016/j.jcis.2022.08.038 ↗
37. A pH-Sensitive Phospholipid Polymeric Prodrug Based on Branched Polyethylenimine for Intracellular Drug Delivery10.1002/macp.201600261 ↗
38. Platinum-Coordinated Dual-Responsive Nanogels for Universal Drug Delivery and Combination Cancer Therapy10.1002/smll.202203260 ↗
39. Light-activated photodeformable supramolecular dissipative self-assemblies10.1038/s41467-022-30969-2 ↗
40. Insight into membrane selectivity of linear and branched polyethylenimines and their potential as biocides for advanced wound dressings10.1016/j.actbio.2016.04.015 ↗
41. Protective Action of Linear Polyethylenimine against Staphylococcus aureus Colonization and Exaggerated Inflammation in Vitro and in Vivo10.1021/acsinfecdis.9b00102 ↗
42. Development of an ultra-high-performance liquid chromatography-charged aerosol detection/UV method for the quantitation of linear polyethylenimines in oligonucleotide polyplexes10.1002/jssc.202000414 ↗
43. Synthesis and characterization of dexamethasone-conjugated linear polyethylenimine as a gene carrier10.1002/jcb.22587 ↗
44. Gene delivery using polymer therapeutics10.1007/12_023 ↗
45. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine10.1016/j.biomaterials.2009.07.012 ↗
46. A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy10.1016/j.ymthe.2005.02.010 ↗
47. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity10.1016/j.addr.2006.09.008 ↗
48. Facile synthesis of folic acid-functionalized iron oxide nanoparticles with ultrahigh relaxivity for targeted tumor MR imaging10.1039/C5TB00849B ↗
49. Facile one-pot synthesis of Fe3O4@Au composite nanoparticles for dual-mode MR/CT imaging applications10.1021/am4034526 ↗
50. Branched polyethyleneimine modified with hyaluronic acid via a PEG spacer for targeted anticancer drug delivery10.1039/C5RA23022E ↗
51. The gene transfection and endocytic uptake pathways mediated by PEGylated PEI-entrapped gold nanoparticles10.1016/j.arabjc.2018.06.009 ↗
52. Mechanistic Studies of Enhanced PCR Using PEGylated PEI-Entrapped Gold Nanoparticles10.1021/acsami.6b09310 ↗
53. Optimization of the composition and dosage of PEGylated polyethylenimine-entrapped gold nanoparticles for blood pool, tumor, and lymph node CT imaging10.1016/j.msec.2017.08.018 ↗
54. Targeted tumor dual mode CT/MR imaging using multifunctional polyethylenimine-entrapped gold nanoparticles loaded with gadolinium10.1080/10717544.2017.1422299 ↗
55. Acetylated Polyethylenimine-Entrapped Gold Nanoparticles Enable Negative Computed Tomography Imaging of Orthotopic Hepatic Carcinoma10.1021/acs.langmuir.8b01669 ↗
56. PEGylated polyethylenimine-entrapped gold nanoparticles loaded with gadolinium for dual-mode CT/MR imaging applications10.2217/nnm-2016-0093 ↗
57. A multifunctional polyethylenimine-based nanoplatform for targeted anticancer drug delivery to tumors in vivo10.1039/C6TB02620F ↗
58. 99mTc-Labeled RGD-Polyethylenimine Conjugates with Entrapped Gold Nanoparticles in the Cavities for Dual-Mode SPECT/CT Imaging of Hepatic Carcinoma10.1021/acsami.7b17107 ↗
59. Cancer nanomedicine based on polyethylenimine-mediated multifunctional nanosystems10.1016/j.pmatsci.2021.100871 ↗
60. Branched polyethylenimine-based PKCalpha-responsive gene carriers10.1080/09205063.2013.807459 ↗
61. Uptake of heavy metals from synthetic aqueous solutions using modified PEI—Silica gels10.1016/S0043-1354(02)00410-4 ↗
62. Characterization of PEI-modified biomass and biosorption of Cu(II), Pb(II) and Ni(II)10.1016/j.watres.2005.03.033 ↗
63. Decarboxylated polyethylenimine-modified bacterial biosorbent for Ru biosorption from Ru-bearing acetic acid wastewater10.1016/j.cej.2013.06.087 ↗
64. Partial Acetylation of Polyethylenimine Enhances In Vitro Gene Delivery10.1023/B:PHAM.0000016251.42392.1e ↗
65. The genotoxicity of PEI-based nanoparticles is reduced by acetylation of polyethylenimine amines in human primary cells10.1016/j.toxlet.2012.12.019 ↗
66. A new biodegradable polymer: PEGylated chitosan-g-PEI possessing a hydroxyl group at the PEG end10.1007/s10965-007-9157-z ↗
67. A serum-tolerant hydroxyl-modified polyethylenimine as versatile carriers of pDNA/siRNA10.1002/mabi.201200346 ↗
68. Effects of electron beam irradiation and hydroxyl ion concentration on morphological stability of polyethylenimine-capped gold nanoparticles10.1088/2053-1591/ab54e2 ↗
69. Effect of Polyethylene Glycol on Gene Delivery of Polyethylenimine10.1248/bpb.26.492 ↗
70. Stability of poly(ethylene glycol)-graft-polyethylenimine copolymer/DNA complexes: Influences of PEG molecular weight and PEGylation degree10.1007/s10856-009-3903-1 ↗
71. Craciun, B.F., Gavril, G., Peptanariu, D., Ursu, L.E., Clima, L., and Pinteala, M. (2019). Synergistic Effect of Low Molecular Weight Polyethylenimine and Polyethylene Glycol Components in Dynamic Nonviral Vector Structure, Toxicity, and Transfection Efficiency. Molecules, 24.10.3390/molecules24081460 ↗
72. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery10.1016/j.colsurfb.2015.07.047 ↗
73. Tumor-Targeting Co-Delivery of Drug and Gene from Temperature-Triggered Micelles10.1002/mabi.201500137 ↗
74. Receptor-mediated gene delivery into human mesenchymal stem cells using hyaluronic acid-shielded polyethylenimine/pDNA nanogels10.1016/j.carbpol.2015.09.053 ↗
75. Self-assembled ternary complexes stabilized with hyaluronic acid-green tea catechin conjugates for targeted gene delivery10.1016/j.jconrel.2016.02.004 ↗
76. A protein–polymer hybrid gene carrier based on thermophilic histone and polyethylenimine10.1039/C5NJ01272D ↗
77. Effect of peptide content on the regulation of transgene expression by protein kinase Calpha-responsive linear polyethylenimine-peptide conjugates10.1016/j.colsurfb.2014.09.004 ↗
78. Intracellular delivery of glutathione S-transferase-fused proteins into mammalian cells by polyethylenimine-glutathione conjugates10.1093/jb/mvn087 ↗
79. Branched polyethylenimine-grafted-carboxymethyl chitosan copolymer enhances the delivery of pDNA or siRNA in vitro and in vivo
80. Low molecular weight PEI-grafted carboxyl-modified soybean protein as gene carriers with reduced cytotoxicity and greatly improved transfection in vitro10.1080/00914037.2018.1482462 ↗
81. New micelle-like polymer aggregates made from PEI–PLGA diblock copolymers: Micellar characteristics and cellular uptake10.1016/S0142-9612(02)00641-5 ↗
82. Block copolymer micelles as vehicles for drug delivery10.1016/0168-3659(93)90172-2 ↗
83. New Insight into the Synthesis and Biological Activity of the Polymeric Materials Consisting of Folic Acid and beta-Cyclodextrin10.1002/mabi.201700289 ↗
84. Hydroxylated Mesoporous Nanosilica Coated by Polyethylenimine Coupled with Gadolinium and Folic Acid: A Tumor-Targeted T(1) Magnetic Resonance Contrast Agent and Drug Delivery System10.1021/acsami.5b04294 ↗
85. Polymer-DNA Hybrid Nanoparticles Based on folate-Polyethylenimine-block-poly(L-lactide)10.1021/bc049754j ↗
86. Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy10.1016/j.colsurfb.2015.06.039 ↗
87. Lee, G.J., and Kim, T.I. (2019). pH-Responsive i-motif Conjugated Hyaluronic Acid/Polyethylenimine Complexes for Drug Delivery Systems. Pharmaceutics, 11.10.3390/pharmaceutics11050247 ↗
88. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery10.1166/jnn.2014.9583 ↗
89. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy10.1016/j.carbpol.2022.119662 ↗
90. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging10.1016/j.biomaterials.2014.01.011 ↗
91. Facile preparation of hyaluronic acid-modified Fe3O4@Mn3O4 nanocomposites for targeted T-1/T-2 dual-mode MR imaging of cancer cells10.1039/C6RA05648B ↗
92. Hyaluronic acid-modified Fe3O4@Au core/shell nanostars for multimodal imaging and photothermal therapy of tumors10.1016/j.biomaterials.2014.10.065 ↗
93. Simultaneous innate immunity activation and immunosuppression improvement by biodegradable nanoplatform for boosting antitumor chemo-immunotherapy10.1016/j.cej.2022.136093 ↗
94. Hyaluronic Acid-Enwrapped Polyoxometalate Complex for Synergistic Near Infrared-II Photothermal/Chemo-Therapy and Chemodynamic Therapy10.1021/acs.biomac.2c00615 ↗
95. Dynamic Effects of Endo-Exogenous Stimulations on Enzyme-Activatable Polymeric Nanosystems with Photo-Sono-Chemo Synergy10.1021/acsami.2c05276 ↗
96. Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune response10.1016/j.jconrel.2011.06.031 ↗
97. Advanced materials and processing for drug delivery: The past and the future10.1016/j.addr.2012.10.003 ↗
98. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery10.1016/j.addr.2022.114177 ↗
99. Effect of micro- and nanoparticle shape on biological processes10.1016/j.jconrel.2021.12.032 ↗
100. Ayub, A., and Wettig, S. (2022). An Overview of Nanotechnologies for Drug Delivery to the Brain. Pharmaceutics, 14.10.3390/pharmaceutics14020224 ↗